Stock Earnings

Question 1

What are Vivos Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Vivos Therapeutics Inc has a total asset of $15, Net loss of $-11

Question 2

What are the key financial ratios for VVOS?

Accepted Answer

Vivos Therapeutics Inc's Current ratio is 2.14, has a Net margin is -73.33, sales per share of $2.98.

Question 3

How is Vivos Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Vivos Therapeutics Inc largest revenue segment is Oral Appliances and Therapeutic Treatments, at a revenue of 13,801,000 in the most earnings release.For geography, United States is the primary market for Vivos Therapeutics Inc, at a revenue of 13,801,000.

Question 4

Is Vivos Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Vivos Therapeutics Inc has a net loss of $-11

Question 5

Does Vivos Therapeutics Inc have any liabilities?

Accepted Answer

yes, Vivos Therapeutics Inc has liability of 7

Question 6

How many outstanding shares for Vivos Therapeutics Inc?

Accepted Answer

Vivos Therapeutics Inc has a total outstanding shares of 5.88

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	17	15	13	16	16	13
Revenue Growth (YoY)	21%	15%	-19%	0%	23%	18%
Cost of Revenue	7	6	5	6	4	2
Gross Profit	9	9	8	10	12	10
Selling, General & Admin	24	19	24	34	31	18
Research & Development	--	--	--	--	--	--
Operating Expenses	25	20	25	35	32	22
Other Non Operating Income (Expenses)	0	0	3	0	0	--
Pretax Income	-17	-11	-13	-23	-20	-12
Income Tax Expense	--	--	--	0	0	0
Net Income	-17	-11	-13	-23	-20	-12
Net Income Growth	42%	-15%	-43%	15%	67%	20%
Shares Outstanding (Diluted)	10.96	5.01	1.21	0.92	0.85	0.73
Shares Change (YoY)	66%	312%	33%	8%	16%	4%
EPS (Diluted)	-1.56	-2.21	-11.13	-25.92	-23.89	-16.52
EPS Growth	-17%	-80%	-56.99%	9%	45%	8%
Free Cash Flow	-15	-13	-12	-20	-18	-5
Free Cash Flow Per Share	-1.36	-2.58	-9.84	-21.73	-21.17	-6.84
Gross Margin	52.94%	60%	61.53%	62.5%	75%	76.92%
Operating Margin	-94.11%	-73.33%	-130.76%	-156.25%	-118.75%	-92.3%
Profit Margin	-100%	-73.33%	-100%	-143.75%	-125%	-92.3%
Free Cash Flow Margin	-88.23%	-86.66%	-92.3%	-125%	-112.5%	-38.46%
EBITDA	-15	-11	-17	-25	-19	-12
EBITDA Margin	-88.23%	-73.33%	-130.76%	-156.25%	-118.75%	-92.3%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-16	-11	-17	-25	-19	-12
EBIT Margin	-94.11%	-73.33%	-130.76%	-156.25%	-118.75%	-92.3%
Effective Tax Rate	--	--	--	0%	0%	0%

Vivos Therapeutics Inc (VVOS) Price

VVOS Stock Price Chart

VVOS Income

Follow-Up Questions